Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies 2018-11-28 19:44
Health Care Originals Announces Strategic Alliance With Healthport For Australia And New Zealand 2018-11-28 15:00
WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan 2018-11-28 08:00
Spring Pharmaceutical Group Inc. Starts Harvesting Seed Pods from Its Acer Truncatum Bunge Planting Bases 2018-11-27 20:00
AirXpanders Announces 4,000th AeroForm Implant 2018-11-27 06:11
Foresee Pharmaceuticals Announces Completion of Last Patient Visit in Registration Phase 3 Study of LMIS 25 mg (fp-001) for the Treatment of Advanced Prostate Cancer 2018-11-26 21:30
Seegene launches a new anti-microbial drug resistance test kit, replacing the conventional culture method 2018-11-26 21:00
Samsung Brings Together Medical Imaging and AI for Radiologists at RSNA 2018 2018-11-26 08:39
WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai 2018-11-22 14:31
Huiyihuiying Released the AI Full Cycle Management Cloud Platform Based on AI 2.0 Technology 2018-11-20 22:50
World Institute of Kimchi: Lactic acid bacteria isolated from kimchi was found to mitigate atopic dermatitis symptoms and adjust the microbiome 2018-11-20 22:00
CStone initiates a bridging Phase I clinical trial for PD-1 antibody CS1003 with first patient dosed in China 2018-11-19 12:54
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-877, an Autotaxin Inhibitor for Idiopathic Pulmonary Fibrosis 2018-11-19 07:00
World Institute of Kimchi: Function-enhanced kimchi inhibits growth of cancer cells 2018-11-16 22:00
WuXi AppTec Opens Its New Medical Device Testing Center in Suzhou 2018-11-16 18:00
MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210 2018-11-16 05:01
Foresee Pharmaceuticals Announces Sr. VP of Pharmaceutics and Manufacturing Appointment 2018-11-15 20:33
China Pharma Holdings, Inc. Reports Third Quarter 2018 Financial Results 2018-11-15 19:00
TWi Biotechnology, Inc. Announces Last Patient Enrolled in Phase 2 Study of AC-201CR for Treatment of Hemophilic Arthropathy 2018-11-15 17:16
Sanofi holds China Health Road Symposium at CIIE 2018-11-14 11:20
1 220 221 222 223 224 421